ArticleInternational journal of biological sciences2026

Dual inhibition of PRMT1 and SUV39H1 suppresses breast cancer progression and enhances immunotherapy response.

Ge Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.